BDBM297398 3-Amino-6-bromo-5-trifluoromethyl-pyridine-2-carboxylic acid ((S)-3,3,3-trifluoro-2-hydroxy-2-methyl-propyl)-amide::US10117858, Example 3::US20240058315, Example 3

SMILES C[C@](O)(CNC(=O)c1nc(Br)c(cc1N)C(F)(F)F)C(F)(F)F

InChI Key InChIKey=FKVGABLCWNRNCT-UHFFFAOYSA-N

Data  7 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 297398   

TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  15nMAssay Description:Potentiation of CFTR F508del mutant (unknown origin) expressed in CHO cells assessed as chloride transport by measuring membrane potential incubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  18nMAssay Description:Potentiation of CFTR F508del mutant (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  25nMAssay Description:Potentiation of CFTR F508 deletion mutant (unknown origin) expressed in HBE cells assessed as change in short circuit current in presence of forskoli...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  43nMAssay Description:Potentiation of wild-type CFTR (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence of ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  55nMAssay Description:Fischer Rat Thyroid (FRT) epithelial cells, stably expressing human ΔF508-CFTR were used as monolayer cultures on permeable supports. Cl− ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent

LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  55nMAssay Description:Fischer Rat Thyroid (FRT) epithelial cells, stably expressing human ΔF508-CFTR were used as monolayer cultures on permeable supports. Cl− ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/24/2024
Entry Details
US Patent

TargetCystic fibrosis transmembrane conductance regulator(Human)
Novartis Institutes For Biomedical Research

Curated by ChEMBL
LigandPNGBDBM297398(US10117858, Example 3 | 3-Amino-6-bromo-5-trifluor...)
Affinity DataEC50:  150nMAssay Description:Potentiation of CFTR G551D mutant (unknown origin) expressed in FRT cells assessed as chloride transport by measuring membrane potential in presence ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed